{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T09:08:22Z","timestamp":1683277702388},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10620-022-07434-7","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:02:36Z","timestamp":1647284556000},"page":"3483-3484","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HCC Mortality Trends\u2014In with ALD (and NAFLD) and Out with HCV"],"prefix":"10.1007","volume":"67","author":[{"given":"Chukwunedum","family":"Aniemeka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana A.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"issue":"4","key":"7434_CR1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ajg.2014.11","volume":"109","author":"SF Altekruse","year":"2014","unstructured":"Altekruse SF, Henley JS, Cucinelli JE et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109:542\u2013553.","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"7434_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","volume":"67","author":"P Bertuccio","year":"2017","unstructured":"Bertuccio P, Turati F, Carioli G et al. Global trends and predictions in HCC mortality. J Hepatol. 2017;67:302\u2013309.","journal-title":"J Hepatol."},{"issue":"4","key":"7434_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/diseases5040020","volume":"5","author":"G Cholankeril","year":"2017","unstructured":"Cholankeril G, Yoo ER, Perumpail RB et al. Rising rates of hepatocellular carcinoma leading to liver transplantation in baby boomer generation with chronic hepatitis C, alcohol liver disease, and nonalcoholic steatohepatitis-related liver disease. Diseases. 2017;5:20.","journal-title":"Diseases."},{"key":"7434_CR4","doi-asserted-by":"publisher","unstructured":"Ramani A, Tapper EB, Griffin C et al. Hepatocellular carcinoma related mortality in the United States, 1999\u20132018. Dig Dis Sci. (Epub ahead of print). https:\/\/doi.org\/10.1007\/s10620-022-07433-8.","DOI":"10.1007\/s10620-022-07433-8"},{"issue":"3","key":"7434_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/hep.23802","volume":"52","author":"S Arora","year":"2010","unstructured":"Arora S, Kalishman S, Thornton K et al. Expanding access to HCV treatment- extension for community healthcare outcomes (ECHO) project: Disruptive innovation in specialty care. Hepatology. 2010;52:1124\u20131133.","journal-title":"Hepatology."},{"issue":"3","key":"7434_CR6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/hep.30161","volume":"69","author":"D Kim","year":"2019","unstructured":"Kim D, Li AA, Perumpail BJ et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69:1064\u20131074.","journal-title":"Hepatology."},{"key":"7434_CR7","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","volume":"362","author":"EB Tapper","year":"2018","unstructured":"Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: Observational study. BMJ. 2018;362:k2817.","journal-title":"BMJ."},{"issue":"12","key":"7434_CR8","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650\u20132666.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7434_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","volume":"74","author":"O Kucukoglu","year":"2021","unstructured":"Kucukoglu O, Sowa JP, Mazzolini GD et al. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol. 2021;74:442\u2013457.","journal-title":"J Hepatol."},{"issue":"4","key":"7434_CR10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younnossi","year":"2019","unstructured":"Younnossi Z, Stepanova M, Ong J et al. Nonalcoholic Steatohepatitits is the Fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17:748\u2013775.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07434-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T17:33:32Z","timestamp":1657906412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07434-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7434"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07434-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"3 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chukwunedum Aniemeka has nothing to disclose. Anjana Pillai has nothing to disclose relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}